Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Imprimis Pharmaceuticals Reports On Third Quarter 2014 Financial Results And Provides Update On Business Developments

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ –Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, today announced financial results for the third quarter ended

Conatus Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results And Program Updates

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results for the quarter and nine months ended September 30, 2014, and…

Epic Sciences Appoints As Vice President Of Human Resources

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 13, 2014 /PRNewswire/ –Epic Sciences announced today the appointment ofToni Wayne as vice president of human resources. Ms. Wayne has more than 20 years of experience as a senior level human resources executive in diverse life sciences companies. At Epic, Ms. Wayne will develop best…

AstraZeneca PLC And Isis Pharmaceuticals, Inc. To Co-Develop Targeted Oligonucleotide Delivery Methods

November 13, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif., Nov. 13, 2014 /PRNewswire/ –Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides. The new delivery approaches seek to target the desired tissue more effectively. The agreement…

Mast Therapeutics Announces Closing Of Underwritten Public Offering

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 13, 2014 /PRNewswire/ –Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of equity securities…

Arena Pharmaceuticals, Inc. To Present At 2014 Healthcare Conference

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 13, 2014 /PRNewswire/ –Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announcedtoday that the company is scheduled to present a corporate overview and update at the Stifel 2014 Healthcare Conference on Tuesday, November 18, 2014, at 8:00 a.m…

Otonomy, Inc. Reports Third Quarter 2014 Financial Results And Provides Corporate Update

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, today reported financial results for the third quarter…

La Jolla Pharmaceutical Company Announces Third Quarter And Year-To-Date 2014 Financial Results And Corporate Highlights

November 13, 2014 – 5:00 am | Edit Post

La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported third quarter and year-to-date 2014 financial results and highlighted recent corporate progress and near-term milestones. Help employers find you! Check…

Zogenix, Inc. To Participate In Healthcare Conference

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Stifel 2014 Healthcare…

Human Longevity Inc. Signs Collaborative Agreement With King’s College London To Access Twinsuk Registry

November 13, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Nov. 13, 2014 /PRNewswire/ — Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced a collaborative agreement with King’s College London to access their TwinsUK Registry.